Herendeen Paul purchased $237K of ELAN
Herendeen Paul purchased 10,000 shares of Elanco Animal Health Inc (ELAN) at $23.68 ($0.24M total) on 2026-08-07.
How this was made
The 30-second read
Why it matters
The only new fact is the director’s open-market purchase details (shares, price, total value, and post-transaction holdings).
Market read
Traders may note the insider buy as a mild sentiment input, but there is no accompanying fundamental update.
What to watch
The absence of a 10b5-1 plan does not confirm informational advantage; it only indicates the trade was not under a pre-set plan.
Background
The article is a SEC Form 4 insider transaction disclosure for Elanco Animal Health Inc.
Ticker impact
Elanco Animal Health director Herendeen Paul bought 10,000 shares in an open-market transaction for about $236,850 on 2026-08-07.
Likely limited near-term impact; any effect would be sentiment-driven and small.
Form 4 insider buys can be read as confidence, but the filing provides no new company-specific operational or financial information, and the trade size is modest versus typical market-moving thresholds.
Market effects
No clear sector read-through because the filing contains no guidance, trial, or regulatory development.
None indicated.
None indicated.
Counterpoint
Insider buys can be driven by diversification, compensation timing, or routine liquidity needs rather than a forward-looking view.
Key entities
- issuerElanco Animal Health Inc
Subject of the Form 4 insider transaction disclosure.
- insiderHerendeen Paul
Director who purchased 10,000 shares on 2026-08-07.
